Skip to main content
Top
Published in: Radiation Oncology 1/2010

Open Access 01-12-2010 | Research

Consequential late effects after radiotherapy for prostate cancer - a prospective longitudinal quality of life study

Authors: Michael Pinkawa, Richard Holy, Marc D Piroth, Karin Fischedick, Sandra Schaar, Dalma Székely-Orbán, Michael J Eble

Published in: Radiation Oncology | Issue 1/2010

Login to get access

Abstract

Background

To answer the question if and to which extent acute symptoms at the end and/or several weeks after radiotherapy can predict adverse urinary and gastrointestinal long-term quality of life (QoL).

Methods

A group of 298 patients has been surveyed prospectively before (time A), at the last day (B), two months after (C) and >one year after (D) radiotherapy using a validated questionnaire (Expanded Prostate Cancer Index Composite). A subgroup of 10% with the greatest urinary/bowel bother score decrease at time D was defined as patients with adverse long-term QoL.

Results

Subgroup and correlation analyses could demonstrate a strong dependence of urinary/bowel QoL after radiotherapy on urinary/bowel QoL before radiotherapy. In contrast to absolute scores, QoL score changes (relative to baseline scores) did not correlate with pretreatment scores. Long-term changes could be well predicted by acute changes. Patients reporting great/moderate bother with urinary/bowel problems at time C reported to have great/moderate bother at time D in ≥ 50%, respectively. In a multivariate analysis of factors for adverse long-term urinary and bowel QoL, score changes at time C were found to be independent predictors, respectively. Additionally, QoL changes at time B were independently predictive for adverse long-term bowel QoL.

Conclusions

Consequential late effects play a major role after radiotherapy for prostate cancer. Patients with greater and particularly longer non-healing acute toxicity are candidates for closer follow-up and possible prophylactic actions to reduce a high probability of long-term problems.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Cheung R, Tucker SL, Ye JS, Dong L, Liu H, Huang E, Mohan R, Kuban D: Characterization of rectal normal tissue complication probability after high-dose external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2004, 58: 1513-1519. 10.1016/j.ijrobp.2003.09.015CrossRefPubMed Cheung R, Tucker SL, Ye JS, Dong L, Liu H, Huang E, Mohan R, Kuban D: Characterization of rectal normal tissue complication probability after high-dose external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2004, 58: 1513-1519. 10.1016/j.ijrobp.2003.09.015CrossRefPubMed
3.
go back to reference Zapatero A, Garcia-Vicente F, Modolell I, Alcantara P, Floriano A, Cruz-Conde A, Torres JJ, Pérez-Torrubia A: Impact of mean rectal dose on late rectal bleeding after conformal radiotherapy for prostate cancer: dose-volume effect. Int J Radiat Oncol Biol Phys 2004, 59: 1343-1351.CrossRefPubMed Zapatero A, Garcia-Vicente F, Modolell I, Alcantara P, Floriano A, Cruz-Conde A, Torres JJ, Pérez-Torrubia A: Impact of mean rectal dose on late rectal bleeding after conformal radiotherapy for prostate cancer: dose-volume effect. Int J Radiat Oncol Biol Phys 2004, 59: 1343-1351.CrossRefPubMed
4.
go back to reference Selek U, Cheung R, Lii M, Allen P, Steadham RE, Vantreese TR Jr, Little DJ, Rosen II, Kuban D: Erectile dysfunction and radiation dose to penile base structures: a lack of correlation. Int J Radiat Oncol Biol Phys 2004, 59: 1039-1046. 10.1016/j.ijrobp.2003.12.028CrossRefPubMed Selek U, Cheung R, Lii M, Allen P, Steadham RE, Vantreese TR Jr, Little DJ, Rosen II, Kuban D: Erectile dysfunction and radiation dose to penile base structures: a lack of correlation. Int J Radiat Oncol Biol Phys 2004, 59: 1039-1046. 10.1016/j.ijrobp.2003.12.028CrossRefPubMed
5.
go back to reference Pinkawa M, Fischedick K, Asadpour B, Gagel B, Piroth MD, Eble MJ: Low-grade toxicity after conformal radiation therapy for prostate cancer - impact of bladder volume. Int J Radiat Oncol Biol Phys 2006, 64: 835-841.CrossRefPubMed Pinkawa M, Fischedick K, Asadpour B, Gagel B, Piroth MD, Eble MJ: Low-grade toxicity after conformal radiation therapy for prostate cancer - impact of bladder volume. Int J Radiat Oncol Biol Phys 2006, 64: 835-841.CrossRefPubMed
6.
go back to reference Michalski JM, Gay H, Jackson A, Tucker SL, Deasy JO: Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys 2010, 76: S123-S129.PubMedCentralCrossRefPubMed Michalski JM, Gay H, Jackson A, Tucker SL, Deasy JO: Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys 2010, 76: S123-S129.PubMedCentralCrossRefPubMed
7.
go back to reference Beckendorf V, Guerif S, Le Prise E, Cosset J, Bougnoux A, Chauvet B, Salem N, Romenstaing P, Luporsi I, Bey P: 70 Gy versus 80 Gy dose escalation getug 06 french trial for localized prostate cancer: mature results. Int J Radiat Oncol Biol Phys 2008, 72: S96-S97.CrossRef Beckendorf V, Guerif S, Le Prise E, Cosset J, Bougnoux A, Chauvet B, Salem N, Romenstaing P, Luporsi I, Bey P: 70 Gy versus 80 Gy dose escalation getug 06 french trial for localized prostate cancer: mature results. Int J Radiat Oncol Biol Phys 2008, 72: S96-S97.CrossRef
8.
go back to reference Kuban DA, Tucker SL, Dong L, Starkschall G, Huang EH, Cheung MR, Lee AK, Pollack A: Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 2008, 70: 67-74.CrossRefPubMed Kuban DA, Tucker SL, Dong L, Starkschall G, Huang EH, Cheung MR, Lee AK, Pollack A: Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 2008, 70: 67-74.CrossRefPubMed
9.
go back to reference Peeters ST, Heemsbergen WD, Koper PC, van Putten WL, Slot A, Dielwart MF, Dielwart MFH, Bonfer JMG, Incrocci L, Lebesque JV: Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 2006, 24: 1990-1996. 10.1200/JCO.2005.05.2530CrossRefPubMed Peeters ST, Heemsbergen WD, Koper PC, van Putten WL, Slot A, Dielwart MF, Dielwart MFH, Bonfer JMG, Incrocci L, Lebesque JV: Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 2006, 24: 1990-1996. 10.1200/JCO.2005.05.2530CrossRefPubMed
10.
go back to reference Al-Mamgani A, van Putten WL, Heemsbergen WD, van Leenders GJLH, Slot A, Dielwart MFH, Incrocci L, Lebesque JV: Update of dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008, 72: 980-988.CrossRefPubMed Al-Mamgani A, van Putten WL, Heemsbergen WD, van Leenders GJLH, Slot A, Dielwart MFH, Incrocci L, Lebesque JV: Update of dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008, 72: 980-988.CrossRefPubMed
11.
go back to reference Dörr W, Hendry JH: Consequential late effects in normal tissues. Radiother Oncol 2001, 61: 223-231. 10.1016/S0167-8140(01)00429-7CrossRefPubMed Dörr W, Hendry JH: Consequential late effects in normal tissues. Radiother Oncol 2001, 61: 223-231. 10.1016/S0167-8140(01)00429-7CrossRefPubMed
12.
go back to reference Schultheiss TE, Lee WR, Hunt MA, Hanlon AL, Peter RS, Hanks GE: Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 1997, 37: 3-11.CrossRefPubMed Schultheiss TE, Lee WR, Hunt MA, Hanlon AL, Peter RS, Hanks GE: Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 1997, 37: 3-11.CrossRefPubMed
13.
go back to reference Heemsbergen WD, Peeters ST, Koper PC, Hoogeman MS, Lebesque JV: Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients: consequential late damage. Int J Radiat Oncol Biol Phys 2006, 66: 3-10.CrossRefPubMed Heemsbergen WD, Peeters ST, Koper PC, Hoogeman MS, Lebesque JV: Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients: consequential late damage. Int J Radiat Oncol Biol Phys 2006, 66: 3-10.CrossRefPubMed
14.
go back to reference Joseph KJ, Alvi R, Skarsgard D, Tonita J, Pervez N, Small C, Tai P: Analysis of health-related quality of life (HRQoL) of patients with clinically localized prostate cancer, one year after treatment with external beam radiotherapy (EBRT) alone versus EBRT and high dose rate brachytherapy (HDRBT). Radiat Oncol 2008, 3: 20. 10.1186/1748-717X-3-20PubMedCentralCrossRefPubMed Joseph KJ, Alvi R, Skarsgard D, Tonita J, Pervez N, Small C, Tai P: Analysis of health-related quality of life (HRQoL) of patients with clinically localized prostate cancer, one year after treatment with external beam radiotherapy (EBRT) alone versus EBRT and high dose rate brachytherapy (HDRBT). Radiat Oncol 2008, 3: 20. 10.1186/1748-717X-3-20PubMedCentralCrossRefPubMed
15.
go back to reference Fransson P, Lund J, Damber J, Klepp O, Wiklund F, Fossa S, Widmark A: Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy; 4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trial. Lancet Oncol 2009, 10: 370-380. 10.1016/S1470-2045(09)70027-0CrossRefPubMed Fransson P, Lund J, Damber J, Klepp O, Wiklund F, Fossa S, Widmark A: Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy; 4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trial. Lancet Oncol 2009, 10: 370-380. 10.1016/S1470-2045(09)70027-0CrossRefPubMed
16.
go back to reference Geinitz H, Thamm R, Scholz C, Heinrich C, Prause N, Kerndl S, Keller M, Busch R, Molls M, Zimmermann FB: Longitudinal analysis of quality of life in patients receiving conformal radiation therapy for prostate cancer. Strahlenther Onkol 2010, 186: 46-52. 10.1007/s00066-009-2023-7CrossRefPubMed Geinitz H, Thamm R, Scholz C, Heinrich C, Prause N, Kerndl S, Keller M, Busch R, Molls M, Zimmermann FB: Longitudinal analysis of quality of life in patients receiving conformal radiation therapy for prostate cancer. Strahlenther Onkol 2010, 186: 46-52. 10.1007/s00066-009-2023-7CrossRefPubMed
17.
go back to reference Pinkawa M, Piroth MD, Fischedick K, Nussen S, Klotz J, Holy R, Eble MJ: Self-assessed toxicity after external beam radiotherapy for prostate cancer - predictive factors on irritative symptoms, incontinence and rectal bleeding. Radiat Oncol 2009, 4: 36. 10.1186/1748-717X-4-36PubMedCentralCrossRefPubMed Pinkawa M, Piroth MD, Fischedick K, Nussen S, Klotz J, Holy R, Eble MJ: Self-assessed toxicity after external beam radiotherapy for prostate cancer - predictive factors on irritative symptoms, incontinence and rectal bleeding. Radiat Oncol 2009, 4: 36. 10.1186/1748-717X-4-36PubMedCentralCrossRefPubMed
18.
go back to reference Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG: Development and validation of the expanded prostate cancer index composite (epic) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 2000, 56: 899-905. 10.1016/S0090-4295(00)00858-XCrossRefPubMed Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG: Development and validation of the expanded prostate cancer index composite (epic) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 2000, 56: 899-905. 10.1016/S0090-4295(00)00858-XCrossRefPubMed
19.
go back to reference Volz-Sidiropoulou E, Pinkawa M, Fischedick K, Jakse G, Gauggel S, Eble MJ: Factor analysis of the Expanded Prostate Cancer Index Composite (EPIC) in a patient group after primary (external beam radiotherapy and permanent iodine-125 brachytherapy) and postoperative radiotherapy for prostate cancer. Curr Urol 2008, 2: 122-129. 10.1159/000189652CrossRef Volz-Sidiropoulou E, Pinkawa M, Fischedick K, Jakse G, Gauggel S, Eble MJ: Factor analysis of the Expanded Prostate Cancer Index Composite (EPIC) in a patient group after primary (external beam radiotherapy and permanent iodine-125 brachytherapy) and postoperative radiotherapy for prostate cancer. Curr Urol 2008, 2: 122-129. 10.1159/000189652CrossRef
20.
go back to reference Ososba D, Rodrigues G, Myles J, Zee B, Pater J: Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998, 16: 139-144. Ososba D, Rodrigues G, Myles J, Zee B, Pater J: Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998, 16: 139-144.
21.
go back to reference Pinkawa M, Fischedick K, Asadpour B, Gagel B, Piroth MD, Nussen S, Eble MJ: Toxicity profile with a large prostate volume after external beam radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008, 70: 83-89.CrossRefPubMed Pinkawa M, Fischedick K, Asadpour B, Gagel B, Piroth MD, Nussen S, Eble MJ: Toxicity profile with a large prostate volume after external beam radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008, 70: 83-89.CrossRefPubMed
22.
go back to reference Pinkawa M, Gagel B, Piroth MD, Fischedick K, Asadpour B, Kehl M, Klotz J, Eble MJ: Erectile dysfunction after external beam radiotherapy for prostate cancer. Eur Urol 2009, 55: 227-236. 10.1016/j.eururo.2008.03.026CrossRefPubMed Pinkawa M, Gagel B, Piroth MD, Fischedick K, Asadpour B, Kehl M, Klotz J, Eble MJ: Erectile dysfunction after external beam radiotherapy for prostate cancer. Eur Urol 2009, 55: 227-236. 10.1016/j.eururo.2008.03.026CrossRefPubMed
23.
go back to reference Muanza TM, Albert PS, Smith S, Godette D, Crouse NS, Cooley-Zgela T, Scinto L, Camphausen K, Coleman CN, Ménard C: Comparing measures of acute bowel toxicity in patients with prostate cancer treated with external beam radiation therapy. Int J Radiat Oncol Biol Phys 2005, 62: 1316-1321.CrossRefPubMed Muanza TM, Albert PS, Smith S, Godette D, Crouse NS, Cooley-Zgela T, Scinto L, Camphausen K, Coleman CN, Ménard C: Comparing measures of acute bowel toxicity in patients with prostate cancer treated with external beam radiation therapy. Int J Radiat Oncol Biol Phys 2005, 62: 1316-1321.CrossRefPubMed
24.
go back to reference Michalski JM, Winter K, Purdy JA, Parliament M, Wong H, Perez CA, Roach M, Bosch W, Cox JD: Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V. Int J Radiat Oncol Biol Phys 2005, 62: 706-713.CrossRefPubMed Michalski JM, Winter K, Purdy JA, Parliament M, Wong H, Perez CA, Roach M, Bosch W, Cox JD: Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V. Int J Radiat Oncol Biol Phys 2005, 62: 706-713.CrossRefPubMed
25.
go back to reference Martin JM, Bayley A, Bristow R, Chung P, Gospodarowicz M, Menard C, Milosevic M, Rosewall T, Wade PR, Catton CN: Image guided dose escalated prostate radiotherapy: still room to improve. Radiat Oncol 2008, 4: 50. 10.1186/1748-717X-4-50CrossRef Martin JM, Bayley A, Bristow R, Chung P, Gospodarowicz M, Menard C, Milosevic M, Rosewall T, Wade PR, Catton CN: Image guided dose escalated prostate radiotherapy: still room to improve. Radiat Oncol 2008, 4: 50. 10.1186/1748-717X-4-50CrossRef
26.
go back to reference Pinkawa M, Pursch-Lee M, Asadpour B, Gagel B, Piroth MD, Nussen S, Eble MJ: Image-guided radiotherapy for prostate cancer. Implementation of ultrasound-based prostate localization for the analysis of inter- and intrafractiuon organ motion. Strahlenther Onkol 2008, 184: 679-685. 10.1007/s00066-008-1902-7CrossRefPubMed Pinkawa M, Pursch-Lee M, Asadpour B, Gagel B, Piroth MD, Nussen S, Eble MJ: Image-guided radiotherapy for prostate cancer. Implementation of ultrasound-based prostate localization for the analysis of inter- and intrafractiuon organ motion. Strahlenther Onkol 2008, 184: 679-685. 10.1007/s00066-008-1902-7CrossRefPubMed
27.
go back to reference Elshaikh MA, Ulchaker JC, Reddy CA, Angermeier KW, Klein EA, Chehade N, Altman A, Ciezki JP: Prophylactic tamsulosin (Flomax) in patients undergoing prostate 125I brachytherapy for prostate carcinoma: final report of a double-blind placebo-controlled randomized study. Int J Radiat Oncol Biol Phys 2005, 62: 164-169. 10.1016/j.ijrobp.2004.09.036CrossRefPubMed Elshaikh MA, Ulchaker JC, Reddy CA, Angermeier KW, Klein EA, Chehade N, Altman A, Ciezki JP: Prophylactic tamsulosin (Flomax) in patients undergoing prostate 125I brachytherapy for prostate carcinoma: final report of a double-blind placebo-controlled randomized study. Int J Radiat Oncol Biol Phys 2005, 62: 164-169. 10.1016/j.ijrobp.2004.09.036CrossRefPubMed
28.
go back to reference Fantin AC, Binek J, Jabar FM, Meyenberger C: Argon beam coagulation for treatment of symptomatic radiation-induced proctitis. Gastrointest Endosc 1999, 49: 515-518. 10.1016/S0016-5107(99)70054-4CrossRefPubMed Fantin AC, Binek J, Jabar FM, Meyenberger C: Argon beam coagulation for treatment of symptomatic radiation-induced proctitis. Gastrointest Endosc 1999, 49: 515-518. 10.1016/S0016-5107(99)70054-4CrossRefPubMed
29.
go back to reference Ehrenpreis ED, Jani A, Levitsky J, Ahn J, Hong J: A prospective, randomized, double-blind, placebo-controlled trial of retinol-palmitate (vitamin A) for symptomatic chronic radiation proctopathy. Dis Colon Rectum 2005, 48: 1-8. 10.1007/s10350-004-0821-7CrossRefPubMed Ehrenpreis ED, Jani A, Levitsky J, Ahn J, Hong J: A prospective, randomized, double-blind, placebo-controlled trial of retinol-palmitate (vitamin A) for symptomatic chronic radiation proctopathy. Dis Colon Rectum 2005, 48: 1-8. 10.1007/s10350-004-0821-7CrossRefPubMed
30.
go back to reference Tran A, Wallner K, Merrick GS, Seeberger J, Armstrong J, Mueller A, Cavanagh W, Lin D, Butler W: Rectal fistulas following prostate brachytherapy. Int J Radiat Oncol Biol Phys 2005, 63: 150-154.CrossRefPubMed Tran A, Wallner K, Merrick GS, Seeberger J, Armstrong J, Mueller A, Cavanagh W, Lin D, Butler W: Rectal fistulas following prostate brachytherapy. Int J Radiat Oncol Biol Phys 2005, 63: 150-154.CrossRefPubMed
Metadata
Title
Consequential late effects after radiotherapy for prostate cancer - a prospective longitudinal quality of life study
Authors
Michael Pinkawa
Richard Holy
Marc D Piroth
Karin Fischedick
Sandra Schaar
Dalma Székely-Orbán
Michael J Eble
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2010
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/1748-717X-5-27

Other articles of this Issue 1/2010

Radiation Oncology 1/2010 Go to the issue